Skip to content
← Lip and Oral Cavity Cancer

HEALTH PROFESSIONAL · SOURCE READING

Treatment Options for Metastatic and Recurrent Lip and Oral Cavity Cancer

Source: Lip and Oral Cavity Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 14, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Metastatic and Recurrent Lip and Oral Cavity Cancer

Treatment options for metastatic and recurrent lip and oral cavity cancer include:

Surgery is the preferred treatment if radiation therapy was used initially.[3]

Source links and citations

Surgery,[3] radiation therapy, or a combination of these treatments may be considered if surgery was used to treat the lesion initially.

Source links and citations

Immunotherapy.[4-12]

Source links and citations

Immunotherapy.[4-12]

Pembrolizumab.

Source links and citations

Immunotherapy.[4-12]

Nivolumab.

Source links and citations

Although chemotherapy has been shown to induce responses, no increase in survival has been demonstrated.[13]

Source links and citations

Clinical trials evaluating new chemotherapy drugs, chemotherapy and re-irradiation, or hyperthermia should be considered because both surgical salvage after primary radiation therapy and radiation therapy after primary surgery give poor results.[14,15]

Source links and citations

Continue within this section

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice